Xlife Sciences AG

CHIX:XLSz (Switzerland)   Ordinary Shares
CHF 35.00 (-3.05%) Jun 6
15.87
P/B:
0.69
Market Cap:
CHF 197.33M ($ 221.67M)
Enterprise V:
CHF 253.64M ($ 284.92M)
Volume:
214.00
Avg Vol (2M):
111.00
Also Trade In:
Volume:
214.00
Avg Vol (2M):
111.00
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Xlife Sciences AG ( CHIX:XLSz ) from 2024 to Jun 07 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Xlife Sciences AG stock (CHIX:XLSz) PE ratio as of Jun 07 2024 is 15.87. More Details

Xlife Sciences AG (CHIX:XLSz) PE Ratio (TTM) Chart

To

Xlife Sciences AG (CHIX:XLSz) PE Ratio (TTM) Historical Data

Total 0
  • 1
Xlife Sciences AG PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data

Xlife Sciences AG (CHIX:XLSz) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Xlife Sciences AG

ISIN : CH0461929603

Share Class Description:

CHIX:XLSz: Ordinary Shares
Compare
Compare
Traded in other countries / regions
XLS.SwitzerlandXLSz.UKXLSCF.USA
IPO Date
2024-04-02
Description
Xlife Sciences AG is a Swiss incubator and accelerator company focused on the value development and commercialization of research projects from universities and other life science research institutions, to provide solutions for high unmet medical needs. It holds majority or minority interests in project companies that are engaged in areas of the company's reportable segments which include Technology platforms, Medical Technology, Biotechnology/Therapeutics, and Artificial intelligence/digital medicine.